日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Screening Based on Structural and Biological Verification of Stachyose as a PPARγ-Modulating Ligand for the Treatment of Non-Alcoholic Fatty Liver Disease.

基于结构和生物学验证筛选水苏糖作为PPARγ调节配体用于治疗非酒精性脂肪肝疾病。

Fang Binbo, Li Mengyuan, Jiang Feng, Dong Weisong, Zhang Weizhi, Lin Lifan, Bai Yongheng, Zheng Jianjian

Identification of key molecular targets for stachyose in hepatocellular carcinoma: focus on STAT3 and FN1.

肝细胞癌中水苏糖的关键分子靶点鉴定:重点关注 STAT3 和 FN1

Chen Haihua, Wang Xianyou, Ying Jiongcheng, Huang YuQin, Liu Yuxi, Feng Yifu, Fang Binbo